FIELD: medicine.
SUBSTANCE: invention describes a method for prediction of the onset of retrochorial hematomas in pregnant women suffering undifferentiated connective tissue dysplasia with threatened early miscarriage without the clinical presentation of gestational sac detachment involving measurement of erythrocyte magnesium wherein the measured erythrocyte magnesium values lower than 1.65 mmole/l in the given group of the pregnant women, the onset of retrochorial hematomas is predicted. The method enables the prediction of developing retrochorial hematomas in pregnant women suffering undifferentiated connective tissue dysplasia with threatened early miscarriage without the clinical presentation of gestational sac detachment.
EFFECT: method is simple and available to implement that enables to use it in practical healthcare.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CHORION SEPARATION IN FIRST TRIMESTER OF PREGNANCY | 2014 |
|
RU2566729C1 |
| METHOD FOR PREDICTING PRIMARY PLACENTA INSUFFICIENCY SEVERITY DEGREE | 2005 |
|
RU2292552C2 |
| METHOD FOR PERICONCEPTIONAL PREDICTION OF RECURRENT EARLY REPRODUCTIVE LOSSES AND PRIMARY PLACENTAL INSUFFICIENCY | 2019 |
|
RU2709246C1 |
| METHOD FOR DIAGNOSTICS OF NON-DIFFERENTIAL CONNECTIVE TISSUE DYSPLASIA IN PREGNANT WOMEN | 2016 |
|
RU2639820C1 |
| METHOD OF PREDICTING PRE-TERM LABOUR IN PATIENTS WITH PRIMARY RECURRENT MISCARRIAGE | 2012 |
|
RU2485896C1 |
| METHOD FOR TREATMENT OF RECURRENT PREGNANCY LOSS RELATED TO RETROCHORIAL HEMATOMA | 2017 |
|
RU2668715C1 |
| METHOD FOR CORRECTION OF NON-DIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA | 2005 |
|
RU2290175C2 |
| METHOD FOR PREVENTING COMPLICATIONS OF PERINATAL PERIOD | 2020 |
|
RU2761315C1 |
| METHOD FOR PREDICTING PREMATURE BIRTH IN WOMEN WITH THREATENED EARLY MISCARRIAGE AND RECURRENT MISCARRIAGE IN HISTORY | 2021 |
|
RU2755269C1 |
| METHOD FOR PREDICTING THREATENED MISCARRIAGE IN WOMEN IN THE I TRIMESTER OF GESTATION | 2022 |
|
RU2784574C1 |
